Infection News

Peri- and postmenopausal women with HPV have lower health-related quality of life compared with premenopausal counterparts, with the strongest differences observed within the sexuality domain, researchers reported.

Nearly 10% of women infected with SARS-CoV-2 during pregnancy had post-acute sequelae 6 or more months later, according to results of the RECOVER-Pregnancy study published in Obstetrics & Gynecology.

Women with asymptomatic or mild COVID-19 infection at the time of frozen embryo transfer did not experience significant adverse early pregnancy outcomes, researchers reported in BMC Pregnancy and Childbirth.

In June, Gilead Sciences announced that its investigational antiretroviral drug lenacapavir prevented 100% of new HIV infections during a phase 3 trial conducted among cisgender women in Africa.

Late last month, members of the U.S. House of Representatives introduced H.R. 8839, the bipartisan Maternal and Infant Syphilis Prevention Act.

After decades of RSV vaccine development, the approvals and recommendations were seen as landmark events in preventive medicine. Uptake was low, however — not unusual for first-year approvals, experts told Healio.

When it comes to screening perinatally exposed infants for hepatitis C virus, the earlier the better, a study showed.

Lenacapavir, an injectable antiretroviral drug approved by the FDA for HIV treatment, prevented 100% of new HIV infections among women in a phase 3 trial in Africa, demonstrating its efficacy as PrEP, Gilead Sciences said.

Infants born to mothers vaccinated against COVID-19 during the omicron wave had decreased risks for preterm birth and adverse neonatal outcomes, according to results of the INTERCOVID-2022 study.

WHO reported a “major” increase in STIs in 2022, specifically highlighting an increase in syphilis and an insufficient decline in new HIV and viral hepatitis infections.